retatrutide nonalcoholic fatty liver disease trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic disease: a randomized phase 2a retatrutide nonalcoholic fatty liver disease
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2



























